MFDS — authorised 16 October 2018
- Marketing authorisation holder: PFIZER INC
- Status: likely_approved
🇰🇷 Talzenna in South Korea
MFDS authorised Talzenna on 16 October 2018
Marketing authorisation
Talzenna in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Talzenna approved in South Korea?
Yes. MFDS authorised it on 16 October 2018.
Who is the marketing authorisation holder for Talzenna in South Korea?
PFIZER INC holds the South Korean marketing authorisation.